Cargando…

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis

INTRODUCTION: Postmenopausal patients with rheumatoid arthritis (RA) are often treated with corticosteroids. Loss of estrogen, the inflammatory disease and exposure to corticosteroids all contribute to the development of osteoporosis. Therefore, our aim was to investigate if addition of the selectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islander, Ulrika, Jochems, Caroline, Stubelius, Alexandra, Andersson, Annica, Lagerquist, Marie K, Ohlsson, Claes, Carlsten, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218911/ https://www.ncbi.nlm.nih.gov/pubmed/21689408 http://dx.doi.org/10.1186/ar3371

Ejemplares similares

Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
por: Stubelius, Alexandra, et al.
Publicado: (2016)

Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
por: Andersson, Annica, et al.
Publicado: (2016)

Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation
por: Jochems, Caroline, et al.
Publicado: (2005)

Trabecular bone loss in collagen antibody-induced arthritis
por: Grahnemo, Louise, et al.
Publicado: (2015)

Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1(*/* )mice with collagen-induced chronic arthritis
por: Jochems, Caroline, et al.
Publicado: (2010)

The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis
por: Engdahl, Cecilia, et al.
Publicado: (2014)

Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
por: Grahnemo, Louise, et al.
Publicado: (2015)

Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis
por: Andersson, Annica, et al.
Publicado: (2015)

Periarticular Bone Loss in Antigen-Induced Arthritis
por: Engdahl, Cecilia, et al.
Publicado: (2013)

Effects of lasofoxifene and bazedoxifene on B cell development and function
por: Bernardi, Angelina I, et al.
Publicado: (2014)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus
por: Nordqvist, Jauquline, et al.
Publicado: (2022)

Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands
por: Islander, Ulrika, et al.
Publicado: (2005)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Interleukin 17A: a Janus-faced regulator of osteoporosis
por: Scheffler, J. M., et al.
Publicado: (2020)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

SUN-744 Phosphorylation Site S122 in Estrogen Receptor α Has a Tissue-Dependent Role in Female Mice
por: Gustafsson, Karin L, et al.
Publicado: (2020)

Physiological levels of estradiol limit murine osteoarthritis progression
por: Corciulo, Carmen, et al.
Publicado: (2022)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss
por: Ohlsson, Claes, et al.
Publicado: (2014)

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

ERα Signaling in a Subset of CXCL12‐Abundant Reticular Cells Regulates Trabecular Bone in Mice
por: Scheffler, Julia M, et al.
Publicado: (2022)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Effect of aerobic exercise and raloxifene combination therapy on senile osteoporosis
por: Zhao, Chengjin, et al.
Publicado: (2016)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Pulsed administration for physiological estrogen replacement in mice
por: Corciulo, Carmen, et al.
Publicado: (2021)

Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
por: Nagai, Noriaki, et al.
Publicado: (2018)

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
por: Torrisi, R, et al.
Publicado: (2001)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
por: Lee, Dong-Yun, et al.
Publicado: (2022)

An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2021)

Panax notoginseng saponins alleviate osteoporosis and joint destruction in rabbits with antigen-induced arthritis
por: Wei, Chen Chao, et al.
Publicado: (2021)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

A tissue-specific role of membrane-initiated ERα signaling for the effects of SERMs
por: Gustafsson, Karin L, et al.
Publicado: (2022)

Reduction of Mature B Cells and Immunoglobulins Results in Increased Trabecular Bone
por: Lagerquist, Marie K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sftermqmu8v0ef0n7i0ndkcing